Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma

Hepatology Research

Volumn 27, Issue 2, 2003, Pages 163-167

  Koda, Masahiko ^a   Maeda, Yoshiko ^a   Matsunaga, Yoshiko ^a   Mimura, Ken Ichi ^a   Murawaki, Yoshikazu ^a   Horie, Yasushi ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Sarcomatous change

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; KERATIN; VIMENTIN; VIRUS RNA;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; ASPIRATION BIOPSY; AUTOPSY; CASE REPORT; CATHETER ABLATION; CELL DIFFERENTIATION; CELL STRUCTURE; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MORTALITY; PRIORITY JOURNAL; SPINDLE CELL; TUMOR BIOPSY; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0142211198     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(03)00207-9     Document Type: Article

References (12)

1. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-71.
2. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001;92:1516-24.
3. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, Uchiyama S, Inoue K. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817-25.
4. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-61.
5. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002;235:466-86.
6. Kojiro M, Sugihara S, Kakizoe S, Nakashima O, Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol 1989;23:4-8.
7. Komada N, Yamagata M, Komura K, Hayashi K, Maruyama T, Kataoka H, Koono M, Tsubouchi H. Hepatocellular carcinoma with sarcomatous change arising in primary biliary cirrhosis. J Gastroenterol 1997;32:95-101.
8. Morishita Y, Etori F, Sawada K, Kachi H, Yamada T, Kawamori T, Tanaka T. Sarcomatous hepatocellular carcinoma with malignant ascites. A report of two cases. Acta Cytol 1998;42:759-64.
9. Haratake J, Horie A. An immunohistochemical study of sarcomatoid liver carcinomas. Cancer 1991;68:93-7.
10. Will O, Mahler HC, Arrigo AP, Epe B. Influence of glutathione levels and heat-shock on the steady-state levels of oxidative DNA base modifications in mammalian cells. Carcinogenesis 1999;20:333-7.
11. Boukamp P, Popp S, Bleuel K, Tomakidi E, Burkle A, Fusenig NE. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Oncogene 1999;18:5638-45.
12. Seki T, Tamai T, Ikeda K, Imamura M, Nishimura A, Yamashiki N, Nakagawa T, Inoue K. Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. Eur J Gastroenterol Hepatol 2001;13:291-4.